Annemieke Kuil – Research output — Amsterdam UMC research portal

Research activity per year

20 Article
4 Comment/Letter to the editor

4 results

Filter

2021

Correction to: The CXCL12gamma chemokine immobilized by heparan sulfate on stromal niche cells controls adhesion and mediates drug resistance in multiple myeloma (Journal of Hematology & Oncology, (2021), 14, 1, (11), 10.1186/s13045-021-01031-3)
Ren, Z., Lantermans, H., Kuil, A., Kraan, W., Arenzana-Seisdedos, F., Kersten, M. J., Spaargaren, M. & Pals, S. T., 1 Dec 2021, In: JOURNAL OF HEMATOLOGY & ONCOLOGY. 14, 1, 29.
Research output: Contribution to journal › Comment/Letter to the editor › Academic

Open Access

2 Citations (Scopus)
2016

Ibrutinib and idelalisib target B cell receptor- but not CXCL12/CXCR4-controlled integrin-mediated adhesion in Waldenström macroglobulinemia
de Rooij, M. F. M., Kuil, A., Kraan, W., Kersten, M. J., Treon, S. P., Pals, S. T. & Spaargaren, M., 2016, In: Haematologica. 101, 3, p. e111-e115
Research output: Contribution to journal › Comment/Letter to the editor › Academic

28 Citations (Scopus)
The pan phosphoinositide 3-kinase/mammalian target of rapamycin inhibitor SAR245409 ( voxtalisib/XL765) blocks survival, adhesion and proliferation of primary chronic lymphocytic leukemia cells (Vol 30, pg 337, 2016)
Thijssen, R., ter Burg, J., van Bochove, G. G. W., de Rooij, M. F. M., Kuil, A., Jansen, M. H., Kuijpers, T. W., Baars, J. W., Virone-Oddos, A., Spaargaren, M., Egile, C., van Oers, M. H. J., Eldering, E., Kersten, M. J. & Kater, A. P., 2016, In: Leukemia. 30, 9, p. 1963
Research output: Contribution to journal › Comment/Letter to the editor › Academic
2015

Ibrutinib and idelalisib synergistically target BCR-controlled adhesion in MCL and CLL: a rationale for combination therapy
de Rooij, M. F. M., Kuil, A., Kater, A. P., Kersten, M. J., Pals, S. T. & Spaargaren, M., 2015, In: Blood. 125, 14, p. 2306-2309
Research output: Contribution to journal › Comment/Letter to the editor › Academic

80 Citations (Scopus)